Diabetes technology is evolving fast. In ATTD Tech Connect, we show how it can help healthcare professionals — nurses, educators, and dieticians — improve therapy and daily life for people living with diabetes.
In this new series sponsored by Medtronic Diabetes, you’ll learn from diverse clinical experience and evidence-based guidance from leaders in diabetes care, tailored for those who support patients every day.
Hosted by Julie Taplin, Dietician and Medtronic Diabetes Education Specialist, the series will explore practical strategies to reduce burden, support meal planning and exercise, and optimize outcomes in real-world care.
Make sure you’re subscribed to the ATTD Podcast feed today.
Explore further resources:
In the final episode of our series on CGM technology, Ginger Vieira explores the future directions for CGM in high-risk pregnancy care with Dr Claire Meek.
They discuss:
High-Risk Pregnancies and Current Gaps in Care
Challenges in Type 2 Diabetes Research
Impact of CGM Technology During Pregnancy
Pre-Pregnancy and Pregnancy Care for Type 2 Diabetes
Third Trimester and Delivery Considerations
Early Adoption of Hybrid Closed Loops
Dr Claire Meek is a Professor of Chemical Pathology & Diabetes in Pregnancy at the University of Leicester in the UK. She’s also an Honorary Consultant Chemical Pathologist & Metabolic Physician at the Addenbrooke’s Hospital.
Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, Ginger Vieira looks at postpartum CGM management, diabetes risk, and what clinicians can do to support women during this significant life event.
She is joined by Dr Grenye O’Malley.
They discuss:
How glucose patterns and insulin needs change postpartum
GDM as a spectrum to Type 2 diabetes
CGM use for early detection of type 2 diabetes after GDM
Strategies for transitioning from intensive pregnancy care to postpartum follow-up
Grenye O'Malley is an Associate Professor in the Division of Endocrinology, Diabetes and Bone Diseases at the Icahn School of Medicine at Mount Sinai. She has research interests in the use of diabetes technologies focusing on health disparities and management of diabetes during pregnancy.
Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, Ginger Vieira explores the common pitfalls of CGM use in pregnancy with Dr Sarit Polsky.
They discuss:
Sarit Polsky is an Associate Professor of Medicine and Pediatrics at the University of Colorado, where she is the Director of the Pregnancy and Women’s Health Clinic. She is Research Director of the Adult Clinic at the Barbara Davis Center for Diabetes and the co-Director of the American College of Diabetology Annual Conference.
Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, Ginger Vieira looks at the latest technology in CGM and what it means for diabetes care during pregnancy.
She is joined by Dr Denice Feig to discuss the latest research and trends in CGM during pregnancy.
They discuss:
How CGM improves maternal and neonatal outcomes
Key clinical trials including the CONCEPTT trial
Evolving trends in CGM use across different types of diabetes in pregnancy (T1D, T2D, GDM)
Dr Denice Feig is a Professor of Medicine in the Division of Endocrinology and Metabolism at the University of Toronto. She is a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and an Adjunct Scientist at ICES. Dr Feig is also the Head of Diabetes and Endocrinology in the Pregnancy Program at Mount Sinai Hospital.
Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In this episode, Dr David Kerr continues his look at AI-driven CGM tools and the future of diabetes and metabolic health. He’s joined by Stanford W. Ascherman Professor of Genetics, Dr Michael Snyder to hear the latest on emerging technologies, and the shift towards integrative and personalised healthcare.
They discuss:
How AI and CGM technology is transforming diabetes and metabolic health management
AI identification of diabetes subtypes and personalised interventions
Impact of physical activity, sleep, and stress on glucose levels, as well as the emerging role of gut microbiome health in metabolic wellness
Potential of AI-driven tools for early intervention and improved health outcomes
Dr Snyder is the Stanford W. Ascherman Professor of Genetics and Director at the Stanford Center of Genomics and Personalized Medicine. He is a leader in the field of functional genomics and proteomics, and co-founder of many biotechnology companies, including Personalis, SensOmics, Qbio @qbioinc, January AI, Filtricine, Mirvie, and Protos.
Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In the first episode of our new series CGM in Focus, supported by Dexcom, host Dr David Kerr takes a closer look at AI-Driven CGM, its impact on the latest technology in continuous glucose monitoring, and what it means in practice for clinicians and patients alike.
To discuss this exciting topic, Dr Kerr is joined by Consultant Physician in Metabolic Medicine, Dr Shivani Misra.
They cover:
The Role of AI in Continuous Glucose Monitoring
Challenges and Potential of AI in Diabetes Management
AI and CGM for Young People with Diabetes
Potential for AI to instigate behaviour change
Dr Shivani Misra is a Consultant Physician in Metabolic Medicine, a Wellcome Trust-funded investigator, and Head of Metabolic Medicine at Imperial College London. Dr Misra specialises in early-onset type 2 diabetes, atypical and non-classical diabetes phenotypes, and congenital hyperinsulinism.
Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In the final episode of our series on Long-Acting Insulin, host Ginger Vieira is joined by David Ahn, MD to answer key questions from fellow clinicians and listeners.
They explore a wide range of topics including:
Dr David Ahn is Program Director and Kris V. Iyer Endowed Chair in Diabetes Care at the Mary and Dick Allen Diabetes Center in Newport Beach, CA. Dr Ahn is a leading digital health speaker, writer, and innovator, and currently serves as the Technology Blog Editor for the nonprofit organization, Taking Control of Your Diabetes.
Visit the Insulin Knowledge Hub on the ATTD Education Portal for further resources and in-depth content on long-acting insulin therapy.
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In today’s episode, host Ginger Vieira is joined by two patients – one with Type 1 and one with Type 2 diabetes – to share their experiences with long-acting insulin.
They cover:
Christel Oerum is the founder of Diabetes Strong, which provides information about diabetes by people living with the condition. She has lived with Type 1 diabetes since 1997.
Real Prince Blue is a podcast host who has lived with Type 2 diabetes since 2016. A retired cop and army vet, Prince documents his fitness journey on social media. Prince recently finished his doctorate in criminal justice.
Visit the Insulin Knowledge Hub on the ATTD Education Portal for further resources and in-depth content on long-acting insulin therapy.
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In today’s episode host Ginger Vieira discusses the latest advancements and emerging trends in long-acting insulin therapy with guest Lucia M. Novak, MSN, ANP-BC, BC-ADM.
They cover:
The latest clinical trials and guidelines
New insulin formations
Smart delivery technologies
The potential of GLP-1 and GIP hormones
Advice on lowering treatment burden and improving the quality of life for those living with diabetes
Lucia is a board-certified Nurse Practitioner with almost 30 years of clinical expertise in diabetes management. She’s a Consultant, Advisor, National Speaker, Author, Educator, Advocate, and is the President and Founder of Diabesity, LLC.
If you’d like to deepen your knowledge on this topic, why not enroll in the e-Learning course ‘Updates and Emerging Trends in Long-Acting Insulin Therapy’ on the Unlok Education website. Led by esteemed experts Dr. Arthi Thirumalai and Prof. Dr. Eda Cengiz, this session delves into recent clinical trials, updated guidelines, and emerging trends that are shaping the future of diabetes management.
This is an accredited activity that gives you 1 CME/CPD credit.
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In today’s episode, host Ginger Vieria is joined by Dr. Egils Bogdanovics to hear perspectives on how to effectively combine long-acting insulin with other diabetes treatments.
They discuss combining long-acting insulin with mealtime insulin, oral medications, and GLP-1 receptor agonists, the role of lifestyle modifications in optimizing insulin effectiveness, and the use of CGM data to refine insulin therapy.
Dr. Egils Bogdanovics is an Assistant Clinical Professor of Medicine at the University of Connecticut. He’s Medical Director at the Charlotte Hungerford Hospital Diabetes Center, and a diplomate of the American Board of Internal Medicine Endocrinology, Diabetes, and Metabolism.
Visit the Insulin Knowledge Hub on the ATTD Education Portal for further resources and in-depth content on long-acting insulin therapy.
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In today’s episode, host Ginger Vieria is joined by Aimée José, RD, CDCES to discuss factors for consideration when initiating, titrating, and monitoring long-acting insulin.
Their conversation provides you with step-by-step guidance on dose titration and adjustments, monitoring and managing adverse effects, and strategies for patient education and engagement during initiation. Aimée draws from her clinical experience working with patients in a non-judgemental manner, encouraging better collaboration between patient and provider.
Aimée José is Principal Clinical Educator at Codex Health. She’s a highly skilled Diabetes Educator with expertise in clinical diabetes care & technology.
Visit the Insulin Knowledge Hub on the Unlok Education website for further resources and in-depth content on long-acting insulin therapy.
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In today’s episode, host Ginger Vieria is joined by pediatric endocrinologist Dr. Ladan Davallow to discuss the factors influencing patient selection.
They explore factors including insulin resistance, lifestyle considerations, and treatment goals, and draw from real-world examples of how clinicians decide on the best candidates for long-acting insulin therapy.
Ladan Davallow, MD is a Pediatric Endocrinologist and Childhood Type 1 Diabetes Consultant & Certified Coach.
She is based in the Medical University of South Carolina Children’s Health Hospital, and is the Co-Founder of and Pediatric Endocrinologist at EndoMD Health, a Virtual Pediatric Endocrine Care Practice.
If you'd like to dive deeper into today’s topic, don’t miss our workshop video: “Patient Selection and Initiation of Long-Acting Insulin Therapy” on the ATTD Education Portal, where Dr. Rodolfo Galindo, Dr. Amit Gupta, Dr. Medha Munshi, Prof. Concetta Irace, and Prof. Raffaella Buzzetti explore two real-world case studies and share expert strategies to guide clinical decisions.
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In today’s episode Ginger Vieria is joined by Diana Isaacs, PharmD, and Endocrine Clinical Pharmacist, to dive deeper into the pharmacokinetics and pharmacodynamics of long-acting insulin.
They explore how long-acting insulin can improve blood glucose levels, reduce the burden of daily injections, and simplify insulin management for the person with diabetes.
Diana Isaacs is a diabetes advocate and speaker. She’s a Director in Education & Training in Diabetes Technology at the Cleveland Clinic, and she’s also a Fellow of the Association of Diabetes Care and Education Specialists (FADCES) and the American College of Clinical Pharmacy (FCCP).
If you’d like to dive deeper into today’s topic, don’t miss our CME/CPD accredited e-learning course, titled Breaking New Ground: Once-Weekly Insulin.
The session delves into the evolution of long-acting insulin therapy and introduces groundbreaking once-weekly formulations. 1 CME/CPD Credit available.
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
In the first episode of ATTD’s brand new series on long-acting insulin, join our host Ginger Vieira and guest Jennifer Okemah, RD, CDCES, as they provide an overview of the role of long-acting insulin in diabetes management, the potential benefits, and the evolution of the different formulations available today.
Jennifer Okemah has been a Registered Dietitian (RD)/Nutritionist since 2005 and a Certified Diabetes Care and Education Specialist (CDCES) since 2007.
She has an additional certification as a Sports Specialist in Dietetics as well as being Board Certified in Advanced Diabetes Management.
Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.
What’s next in long-acting insulin therapy? Find out in ATTD Diabetes Talks: Long-Acting Insulin Uncovered, a new podcast for healthcare professionals who want to stay ahead in diabetes care.
Hosted by Ginger Vieira and powered by ATTD, this series brings you real conversations with CDCESs, PharmDs, pediatric endocrinologists, and people living with diabetes.
We’ll dive into the latest trends, explore clinical benefits, discuss patient selection strategies, and share real-world success stories to help you apply new insights in your practice.
Subscribe now and join us as we uncover how long-acting insulin is shaping the future of diabetes management.
In this episode of ATTD 2025 Conference Catch-Up, we dive into Toward the Cure of Type 1 Diabetes, featuring exciting discussions on cutting-edge strategies, from gene therapy to biomaterials, aimed at advancing beta cell replacement and ultimately finding a cure for type 1 diabetes.
Join us as we summarize key takeaways from these thought-provoking presentations:
This episode is an essential listen for endocrinologists, diabetes researchers, clinicians, and healthcare professionals interested in the latest advances in curative therapies, including gene therapy, biomaterials, and novel treatments aimed at reversing type 1 diabetes.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.
In this episode of ATTD 2025 Conference Catch-Up, we dive into View, Counterview: Time in Tight Range Should Be the Primary Treatment Goals and Outcome Measure in Diabetes, featuring a lively debate on the role of time in tight range as a primary treatment goal, weighing the benefits of advanced CGM technology against the potential psychological and practical challenges.
Join us as we summarize key takeaways from these thought-provoking presentations:
This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to explore the role of tight glycemic control in diabetes management, understand the advantages and challenges of using time in range as an outcome measure, and gain insight into the evolving landscape of diabetes care.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.
In this episode of ATTD 2025 Conference Catch-Up, we dive into Debate: Is There a Real Unmet Need for Continuous Ketone Monitoring?, featuring a compelling discussion on the potential benefits and challenges of continuous ketone monitoring, exploring its role in preventing diabetic ketoacidosis and its place in diabetes management.
Join us as we summarize key takeaways from these thought-provoking presentations:
This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to understand the potential clinical impact of continuous ketone monitoring in diabetes management, its role in preventing complications, and its future integration into patient care.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.
In this episode of ATTD 2025 Conference Catch-Up, we dive into AI-Driven Healthcare: Opportunities and Challenges, featuring discussions on the transformative potential of AI in diabetes and hypertension management, along with the challenges of integrating machine learning into clinical practice while ensuring patient safety and regulatory compliance.
Join us as we summarize key takeaways from these thought-provoking presentations:
This episode is an essential listen for endocrinologists, diabetes specialists, data scientists, and healthcare professionals looking to explore the latest advancements in AI and machine learning technologies, and how they are shaping the future of personalized healthcare, diabetes management, and diagnostic accuracy.
Enjoy the listen!
This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.
ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com
